Scientific Programme

The Cathederal, Zagreb

Saturday Sunday Monday Tuesday Wednesday

TUESDAY 28 May 2002

08:00 - 18:00 Registration

PLENARY SESSION 7

GENETICS

08:30 - 09:30 Main Auditorium

Chairs:Tim Spector (London, UK),
Andre Uitterlinden (Rotterdam, The Netherlands)

08:30 I-20 Treasure your exceptions: genetic mapping of skeletal dysplasias Clair Francomano (Bethesda MD, USA)

09:00 I-21 Progress in mapping osteoporosis genes in mice Robert Klein (Portland OR, USA)

ORAL PRESENTATIONS 6

GENETICS

09:30 - 10:18 Main Auditorium

Chairs:Tim Spector (London, UK), Andre Uitterlinden (Rotterdam, The Netherlands)

09:30 O-27 COLIA1 SP1 BINDING SITE POLYMORPHISM PREDISPOSES TO OSTEOPOROTIC FRACTURES BY ALTERING COLLAGEN PRODUCTION AND IMPAIRING BONE MINERALISATION T. L. Stewart1*, P. Roschger2, B. Grabner2, P. Fratzl3, V. Mann1, R. M. Aspden1, K. Klaushofer2, S. H. Ralston1 1Bone Research Group, University of Aberdeen, UK; 2Ludwig Boltzman Institute of Osteology, Vienna, Austria; 3Erich Schmid Institute of Material Science, Leoben, Austria

09:42 O-28 INTERACTION BETWEEN POLYMORPHISMS IN THE METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) GENE AND THE COLLAGEN TYPE I ALPHA 1 (COLIA1) GENE IN BONE MINERAL DENSITY AND FRACTURE RISK J. B. J. van Meurs1*, P. Arp1, M. van der Klift2, A. Hofman2, H. A. P. Pols1,2, A. G. Uitterlinden1,2 1Department of Internal Medicine, Erasmus University Centre, Rotterdam, The Netherlands; 2Department of Epidemiology and Biostatistics, Erasmus University Centre, Rotterdam, The Netherlands

09:54 O-29 ASSOCIATION STUDY OF THE CDX-2 POLYMORPHISM IN THE 1A PROMOTER REGION OF THE HUMAN VITAMIN D RECEPTOR GENE AND FRACTURE Y. Fang1*, J. B. J. van Meurs1, A. Hofman2, H. P. T. M. van Leeuwen1, C. M. van Duijn2, H. A. P. Pols1,2, A. G. Uitterlinden1,2 1Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands; 2Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands

10:06 O-30 POLYMORPHISMS OF THE TNFR2 GENE ARE ASSOCIATED WITH BONE MINERAL DENSITY IN WOMEN FROM THE UK O. M. E. Albagha*, P. N. Tasker, F. E. A. Mcguigan, D. M. Reid, S. H. Ralston Dept of Medicine and Therapeutics, University of Aberdeen, Aberdeen, UK

10:18 - 10:45 Coffee Break

WORKSHOP 3

CLINICAL CASES

10:45 - 12:15 Main Auditorium

Chairs: Francis Glorieux (Montreal, Canada),
Roger Smith (Oxford, UK)

10:45 O-31 CONGENITAL PSEUDARTHROSIS OF THE TIBIA: TREATMENT WITH A BONE MORPHOGENETIC PROTEIN (OP-1 DEVICE) D. Anticevic1*, Z. Stanec2, M. Jelic1, S. Vukicevic3 1Department of Orthopedic Surgery, Medical School, Zagreb, Croatia; 2Department of Plastic Surgery, Medical School, Zagreb, Croatia; 3Department of Anatomy, Medical School, Zagreb, Croatia

11:05 O-32 OSTEOPETROSIS WITH SPARSE HAIR AND DENTAL DYSPLASIA - AN UNUSUAL PRESENTATION CASE REPORT I. Baric1*, V. Kusec2, V. Sarnavka3, M. Cuk1, D. Krpan4, S. Mutar-Susic5, I. Skrinjaric5, D. Begovic1 1Department of Pediatrics, Clinical Hospital Centre, Zagreb, Croatia; 2Clinical Institute of Laboratory Diagnosis, Clinical Hospital Centre, Zagreb, Croatia; 3Department of Dermatology, Clinical Hospital Centre, Zagreb, Croatia; 4General Hospital 'Sveti Duh', Zagreb, Croatia; 5School of Dentistry, Zagreb, Croatia

11:25 O-33 OSTEOPETROSIS - PLAIN FILM RADIOGRAPHS VS MRI - CASE REPORT OF ADOP II TYPE P. Marusic1*, L. J. Vojnic1, H. Landeka2, B. Brkljacic1 1Department of Radiology, University Hospital 'Dubrava', Zagreb, Croatia; 2Department of Neurology,University Hospital 'Dubrava', Zagreb, Croatia

11:45 O-34 NEUROENDOCRINE TUMOR CAUSING FGF23-INDEPENDENT ONCOGENIC HYPOPHOSPHATEMIC OSTEOMALACIA F. Paglia1*, A. Corsi2,3, S. Minisola1, S. Dionisi1, S. De Geronimo1, S. Licci2, A. Marzullo2, F. Malchiodi4, M. Riminucci2,3, P. Bianco2 1Department of Clinical Science, La Sapienza University, Rome, Italy; 2Department of Experimental Medicine and Pathology, La Sapienza University, Rome, Italy; 3Department of Experimental Medicine, Laboratory of Pathology, University of L'Aquila, Italy; 4Laboratory of Ultrastructure, ISS, Rome, Italy

WORKSHOP 4

FUNCTIONAL GENOMICS

10:45 - 12:15 Small Auditorium

Chairs: Martin Hewison (Birmingham, UK),
Hans van Leeuwen (Rotterdam, The Netherlands)

10:45 I-22 Harvesting biological data using bioinformatics:   prediction of human disease genes Jack Leunissen (Nijmegen, The Netherlands)

11:15 I-23 Application of proteomics to elucidate mechanisms of disease Laura Lawrie (Aberdeen, UK)

11:45 I-24 Probing gene function by transgenic approaches Marian Young (Bethesda MD, USA)

12:15 - 14:00 Lunch and Poster Session 3

Between 12:15 and 13:15 all posters will be attended by their presenting author.

PLENARY SESSION 8

OSTEOCYTES / MECHANICAL LOADING

14:00 - 15:00 Main Auditorium

Chairs: Paolo Bianco (Rome, Italy),
Slobodan Vukicevic (Zagreb, Croatia)

14:00 I-25 Bone cells' responses to mechanical strain: implications for postmenopausal osteoporosis Lance Lanyon (London, UK)

14:30 I-26 What type of exercise protects the skeleton? Ari Heinonen (Tampere, Finland)

ORAL PRESENTATIONS 7

REGULATION OF OSTEOGENESIS

15:00 - 16:12 Main Auditorium

Chairs: Paolo Bianco (Rome, Italy),
Slobodan Vukicevic (Zagreb, Croatia)

15:00 O-35 VARIATION IN HUMAN BONE CELL RESPONSE TO STIMULATION BY FLUID FLOW OR CYCLIC STRAIN M. Mullender1*, A. J. El Haj2, Y. Yang2, J. Magnay2, M. A. van Duin1, J. Klein-Nulend1 1Dept. Oral Cell Biology, ACTA-Vrije Universiteit, Amsterdam, The Netherlands; 2Centre for Science and Technology in Medicine, Dept. Biomedical Eng., Stoke-on-Trent, UK

15:12 O-36 THE BONE-SPECIFIC TRANSCRIPTIONAL REGULATOR CBFA1 IS A TARGET OF MECHANICAL SIGNALS IN OSTEOBLASTIC CELLS P. G. Ziros1, A-P. Rojas Gil1, T. Georgakopoulos1, E. K. Basdra2, A. G. Papavassiliou1* 1Department of Biochemistry, School of Medicine, University of Patras, GR-26110 Patras, Greece; 2Department of Orthodontics, Heidelberg University, D-69120 Heidelberg, Germany

15:24 O-37 PROTEIN KINASE C ALPHA / ESTROGEN RECEPTOR ALPHA INTERACTION IN OSTEOBLAST DIFFERENTIATION M. Longo1*, M. Brama1, M. Marino2, K. S. Korach3, W. C. Wetsel4, R. Scandurra2, T. Faraggiana2, R. Baron5, A. Teti1, S. Migliaccio1,2 1Department of Experimental Medicine, University of L'Aquila, Italy; 2University 'La Sapienza', Rome, Italy; 3NIEHS, Research Triangle Park, NC, USA; 4Duke University Medical Center, Durham, NC, USA; 5Dept Orthop. & Cell Biology, Yale Univ., New Haven, CT, USA

15:36 O-38 METALLOPROTEINASE-14 IS INDUCED AT BEGINNING OF OSTEOGENESIS IN VITRO AND ITS DOWN-REGULATION IS REQUIRED FOR OSTEOGENIC PROGRESSION D. Palmieri, S. Poggi, V. Ulivi, P. Manduca* Dobig, University of Genova, Italy

15:48 O-39 DIFFERENTAL EXPRESSION OF CCN-FAMILY MEMBERS DURING OSTEOGENESIS, CHONDROGENESIS AND ADIPOGENESIS USING PRIMARY HUMAN MESENCHYMAL STEM CELLS N. Schütze*, U. Nöth, J. Schneidereit, C. Hendrich, J. Eulert, F. Jakob Orthopädische UniversitätsklinikClinic, Labor für Molekulare Experimentelle Orthopädie, Würzburg, Germany

16:00 O-40 OP-1 DEVICE IN SURGICAL TREATMENT OF THE SCAPHOID BONE NON-UNION R. Bilic1*, M. Jelic1,2, M. Pecina1, S. Vukicevic2 1Department of Orthopedic Surgery, School of Medicine, University of Zagreb, Croatia; 2Departments of Anatomy, School of Medicine, University of Zagreb, Croatia

Coffee Break

16:12 - 16:30

SATELLITE SYMPOSIUM

BONE FORMING AGENTS: THE NEW PARADIGM FOR OSTEOPOROSIS MANAGEMENT

Sponsored by Eli Lilly & Co

16:30 - 18:00 Small Auditorium

Co-Chairmen: Graham Russell (Oxford, UK),
Robert Neer (Boston MA, USA)

16:30 Introduction: effects of bone active agents on bone cells Graham Russell (Oxford, UK)

16:40 Effects of bone forming agents on bone strength and architecture Juliet Compston (Cambridge, UK)

17:00 Teriparatide and the treatment of osteoporosis: clinical results to date Robert Neer (Boston MA, US)

17:20 Strategy and tactics in the management of severe osteoporosis: who to treat John Kanis (Sheffield, UK)

17:40 Q&A

Chairmen and Panel

20:00 - 23:00 CLOSING PARTY

Wednesday 29 May